Agilent Technologies Cash Flow from Operating Activities 2010-2025 | A
Agilent Technologies annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Agilent Technologies cash flow from operating activities for the quarter ending January 31, 2025 was $431M, a 11.13% decline year-over-year.
- Agilent Technologies cash flow from operating activities for the twelve months ending January 31, 2025 was $4.270B, a 1.5% increase year-over-year.
- Agilent Technologies annual cash flow from operating activities for 2024 was $1.751B, a 1.19% decline from 2023.
- Agilent Technologies annual cash flow from operating activities for 2023 was $1.772B, a 35.06% increase from 2022.
- Agilent Technologies annual cash flow from operating activities for 2022 was $1.312B, a 11.65% decline from 2021.
| Agilent Technologies Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $1,751 |
| 2023 | $1,772 |
| 2022 | $1,312 |
| 2021 | $1,485 |
| 2020 | $921 |
| 2019 | $1,021 |
| 2018 | $1,087 |
| 2017 | $889 |
| 2016 | $793 |
| 2015 | $512 |
| 2014 | $731 |
| 2013 | $1,152 |
| 2012 | $1,228 |
| 2011 | $1,260 |
| 2010 | $718 |
| 2009 | $408 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $30.971B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||